Tokyo-headquartered Takeda is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue. The company traces its origins back to 1781.
Today, Takeda focuses on four therapeutic areas: oncology, rare genetics and haematology, neuroscience, and gastroenterology. It also makes targeted R&D investments in plasma-derived therapies and vaccines.
The Grange Castle site is growing from strength to strength thanks to a great team and strong investment in our people and technology. The treatment produced here will be delivered to patients within 72 hours of being released from Grange Castle which means we are closer to the patient than we have ever been and this brings a great sense of pride to our team.